1. Monitoring treatment response and metastatic relapse in advanced bladder cancer by liquid biopsy analysis;Birkenkamp-Demtroder;Eur Urol,2018
2. Cell-free DNA as a prognostic biomarker for monitoring muscle-invasive bladder cancer;Carrasco;Int J Mol Sci,2022
3. Circulating tumor DNA analysis in advanced urothelial carcinoma: insights from biological analysis and extended clinical follow-up;Lindskrog;Clin Cancer Res,2023
4. ctDNA guiding adjuvant immunotherapy in urothelial carcinoma;Powles;Nature,2021
5. Powles T, Bellmunt J, Jensen JB, et al. Clinical outcomes in patients with high-risk post-cystectomy MIBC with persistent circulating tumor DNA-negative status on serial testing: surveillance analysis from the IMvigor011 study. Presented at the 2024 European Association of Urology Conference, Paris, France.